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ETHICS CENTER

BIOETHICS
CONFERENCE
SLATED
FOR APRIL
"Biomedical Ethics Today: Old
Models and New," a conference for
physicians, nurses, ministers and
other interested persons, will be
held at Loma Linda University April
21-22, 1985. The LLU Center for
Christian Bioethics and the Institute
for Society, Ethics and the Life
Sciences of Hastings-on-the-Hudson, New York, will collaborate in
the presentations.
A discussion of ethical issues in
organ transplantation, presented by
Arthur Caplan, Ph.D., Associate for
the Humanities at the Hastings
Center, will be one of the conference's special features. This lecture,
(continued on page 2)

ROBERT VEATCH TO LECTURE
IN JANUARY AT LOMA LINDA
Robert M. Veatch, Professor of
Medical Ethics, Kennedy Institute
of Ethics, Georgetown University,
and a noted author will deliver the
inaugural address of the Medicine
and Society Conferences, a series
of monthly meetings sponsored by
the Center for Christian Bioethics
and Loma Linda University School
of Medicine. Veatch's topic is
"Human Experimentation: The Process of Ethical Decision-making."
The Veatch lecture will be held
January 16, 1985, from 12 noon to
1:00 p.m. in the Lobby Level Amphitheater of LLUMC. Subsequent conferences will be held on the second
Wednesday of the month.
Jack Provonsha, Directo'r of the
Ethics Center, will formally respond
to Veatch's lecture.
Although the first conference will
be a lecture, normally the format
will include brief statements by an
interdisciplinary panel of profes-

CHARLES TEEL JR. WILL LEAD
CENTRAL AMERICA PROBE
Students in "Biblical Ethics in the
Modern World," a new undergraduate course, along with students in
the Honors Program of Loma Linda
University's College of Arts and
Sciences, will have an opportu~ity
to explore the relationsh ips between
Biblical ethics, Christian ethics, and
social change during a tour of
Mexico and Central America led by
Charles Teel, Jr., Chairman of the
Department of Christian Ethics.
During both the upcoming Christmas vacation and the 1985 Spring
vacation, students in these classes
will interview leaders in Mexico
from groups as diverse as the

Maryknoll Order and the Campus
Crusade for Christ. Those who will
be interviewed include a mother
rearing four children in a "squatters
settlement" in Cuernavaca, a cofounder of Christians for Socialism,
an evangelist with Campus Crusade
for Christ, a professor at a Baptist
theological seminary, the Roman
Catholic Bishop of Cuernavaca,
and a leader of a "base Christian
community."
On November 18, Professor Teel,
a sociologist and ethicist who has
led study tours for several years,
presented the 1984 Lewis Lecture
(continued on page 8)

sionals followed by an open discussion. Members of the panel will
typically include a physician, an
ethicist or theologian and a member
of such professions as law, social
work, public health or hospital administration, depending on the discussion topic.
The conference, open to all interested persons, wi II be a resou rce for
health care professionals from
LLUMC and the Inland Empire.
Prior to each meeting, information
fliers will be sent to hospitals,
agencies and interested persons in
the area.
Funding for the first year of conferences has been provided by the
Wuchenich Foundation. The budget
for the first year, in excess of
$7,500, covers honoraria and travel
for speakers and panelists, publicity, and bibliographic material for
each session. The budget also provides for videotaping the conferences for instructional use by the
University. The tapes will also be
made available to individuals and
institutions at a nominal charge.
The monthly conferences are
administered by a subcommittee of
the Ethics Center Board of Councilors. Members of that committee
are LLU Faculty: David Larson,
Associate Professor of Christian
Ethics; Gordon Thompson, Associate Professor of Medicine; and R.
Bruce Wilcox, Professor of Biochemistry. The committee is chaired
by James Walters, Assistant Professor of Christian Ethics.
The January 16 session is the first
in a cluster of three conferences
dealing with the appropriate use of
new medical technologies. The topic
of the second conference is crossspecies transplantation. The third
conference will deal with the allocation of scarce medical resources.

CONFERENCE

(continued)

scheduled for Sunday, April 21, at
7:30 p.m. will be open to the public.
Other speakers are Daniel Callahan and Ronald Sayer of the
Hastings Center, and Jack Provonsha, David Larson, James WaIters and Charles Teel, Jr., of the
LLU Ethics Center. They will explore
ethical issues surrounding birth and
death, allocation of health care,
ethics of experimenting upon living
beings, and other topics.
The conference will consist of
seven gO-minute sessions. Each
session will begin with a 3D-minute
lecture by one of the ethicists, and
two 12-minute responses by commentators will follow . A moderator
will then lead a ' discussion with
opportunity for audience participation. The first session will begin
Sunday morning, April 21, and the
conference will conclude with three
meetings on Monday, April 22.
Commentators and moderators
are being chosen for their expertise
in the topics covered. Each of the
three speakers of the Hastings Center will comment on another speaker's presentation. The other commentators and moderators will be
chosen from academic and medical
institutions in Southern California.
Although the conference will deal
with biomedical issues, many nonmedical persons will be interested
in these socially important topics.
·AII are welcome. The conference
will have national advertising, although medical professionals in the
West will be the target audience.
For more information about the
conference and for registration
materials, please fill out the response form in this newsletter and
mail it the the Ethics Center.
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REFLECTIONS
.REGARDING BABY FAE .
ETHICAL ISSUES EVOKED BY BABY FAE
James w. Walters
Baby Fae survived four times longer than any
newborn with any type of heart transplant. The historic
nature of this feat is settled, but its value variously is
deemed success or failure. Such controversy is more
good than bad. We'd be in trouble if a baboon heart
transplant caused nary a social ripple. Debate,
discussion and eventual consensus is indispensable if
society is to remain intact as it encounters the totally
new.
This transplant was clearly a scientific marvel, but
some societal issues raised remain opaque. Time and
effort are required for millions of c.itizens to process the
unusual - even the beneficially unusual. Not out of
callousness to the value of Baby Fae's extended life,
but because of our profound regard for all human life,
must we grapple with basic ethical questions which
emerge from, but are not limited to, the recent baboon
heart transplant. Hard questions must be asked of all
bold new procedures in human treatment. I will
develop one question evoked by Baby Fae's experience
and mention three others.
1. Does the experimental nature of a procedure
override its therapeutic intent? Most of us don't flinch
at using white mice as "experimental animals", but
human beings never! Of course, humans share the
mortal nature of all animals, but of tremendous
importance is the way we die. A quick natural death is
morally preferable to an artificially prolonged suffering
death - even if many others stand to benefit. To exploit
innocent individuals for the good of others is morally
suspect. Therefore, participation of human subjects in
original procedures presupposes ajustifiable likelihood

"The Medical Center commendably exceeded the federal government's minimal requirements by having the IRB examine this
privately-funded research."
of personal therapeutic "benefit" - albeit a word of
new meaning in the context of fatal disease. For good
reason medical researchers often utilize thousands of
sub-human subjects to perfect a therapy before
applying it to human beings.
In the case of Baby Fae, the Loma Linda University
Medical Center's I nstitutional Review Board reasoned
that the benefit to the infant was worth the risk. The
Medical Center commendably exceeded the federal
government's minimal requirements by having the IRB
examine this privately-funded research. However, the
thoroughness of that decision-making process is yet to
be fully elaborated. More light will dispell the darkness
in the public media on which some experts - medical
and ethical - have based negative conclusions. The

criticism of unjustified experimentalism may simply
evaporate when the scientific facts and ethical
procedures are better known.
Other major adv~nces in heart transplantation have
been preceded by considerable published scientific
literature and public discussion. The discussion leading
to human heart transplants lasted over a decade. The
determination and approval of the ethical protocol
leading to Barney Clark's artificial heart transplant
took 18 months. Although there is no formula for
adequate prior or subsequent discussion, a presumption toward open communication and broad consensus
is ethically desirable.

"Heart transplants for some babies pose
profound questions when many other
babies in our nation receive inadequate
prenatal care and when still others starve to
death in drought-stricken areas of the
world."
2. Is the consent of the parents truly informed? The
rule of informed consent is difficult to apply in any
case, but when "information" is non-existent due to the
procedure's experimental nature the rule requires that
utmost sensitivity be exercised. Parents with a
terminally-ill newborn are extremely vulnerable and a
third mile must be walked to protect their autonomy.
Are the options for therapy, or lack thereof, presented
in clear and unbiased language? Are the best possible
predictions of quality-of-life told? Is every reasonable
safeguard taken to guarantee an informed, objective
environment of decision-making? To insure that
Barney Cla,k's decision was uncoerced, a knowledgeable "outside" physician was provided to the patient as
his consultant and advocate.
3. Is cross-species heart transplantation a wise use of
limited medical resources? Because the cross-species
heart transplantation is a costly "rescue" measure
rather than a preventive technique, some instinctively
question its appropriateness. Although morbidity and
mortality rates were drastically reduced by public
health measures, we should not conclude that society
should invest all its medical dollars in prevention. A just
allocation of the medical dollar will proportionally
address the needs of all , both prevention and therapy.
A basic fact illumines the Baby Fae case: the actual
cost of the baboon heart transplant was relatively
low. Although some new drugs cost hundreds of
millions of dollars for research and development,
and although the National I nstitutes for Health
expended $180 million dollars developing its artificial
(continued on page 6)
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THE BEST AVAILABLE THERAPY
Jack W. Provonsha
One of the goals of medical research is to discover
tolerable, practical alternatives to untimely death tolerable, because there are worse conditions than
death (medicine is concerned not only with the
quantity, but with the quality of life) - practical,
because while theoretically possible some alternatives
may not in fact be available. The investigation that
preceded it and the actual transplantation of a sevenmonth old baboon heart into Baby Fae's chest on
October 26 were carried out with this larger purpose in
mind and it is important to remember this when
reviewing the controversial Baby Fae case.
Organ replacement, either by the transplant of
organs from donor sources or by mechanical devices is
an example of attempts to achieve.this therapeutic
goal. Unfortunately, for the transplant of organs there
are not, and probably will never be, enough human
donors available to supply the need. This is especially
true for the neonate because of special difficulties
peculiar to that period of life. For one thing, neonates
are rarely involved in the death by accident or violence
that constitutes the primary source of donor organs for
older members of the population. Finding a newborn
who has suffered brain-death but posseses a healthy
heart undamaged by the circumstances often associated with neonatal brain-death, and is of the right size
and tissue type, and in the right geographic location so
that transport time does not compromise the organ,
and for whom proxy donor consent has properly been
given, present a complex of difficulties (further
compounded if the recipient is already moribund) that
render availability unlikely. Add to this the difficulty
experienced in diagnosing isolated brain-death in the
newborn, and one comes to see the practical limits of
the allograft alternative for newborns. If an allograft
were found it would seem an extraordinary coincidence
almost guaranteeing that tissue-type selection would
be limited. Cardiac allografts do not at present appear
to provide the practical alternative to the untimely
death we seek. Practical mechanical hearts still remain
a distant vision and no one that I know of is preparing
one for neonates.
Two other alternatives must therefore be considered.
One of these is the Norwood procedure - a several
stage surgical effort to rearrange the structures of the
hypoplastic left heart so as to permit the right ventrical

"There are worse conditions than death."
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to carry the load of the missing left. The procedure is
still highly experimental with a prohibitive mortality
rate and of dubious long range outcome - including a
questionable quality of life. A successful surgical result
provides somewhat greater longevity, but with a
critically limited heart for the remainder of the child's
life.
The only other present alternative is the xenograft
route taken by Dr. Leonard Bailey at Loma Linda. The
practicality of this approach derives from the fact that
donor organs are readily available, that is if one uses
baboons (most of the other larger primates are
protected species). There are other advantages. One

does not have to wait for brain-death to occur before
harvesting baboon hearts. This virtually guarantees
healthy, functional donor organs. The proper size can
easily be selected and one has some control over time
factors both for donor transport and adequate tissue
testing.
The main practical drawback is, of course, xenograft
rejection and here the precedents are not encouraging,
to say the least. A fair number of xenograft transplants
have been attempted in the past with dismal results in
every instance.
There are some interesting innovations in the case of
Baby Fae, however, raising the possibility of a different
outcome. First, the immunological investigation of
potential animal donors has proceded far beyond
anything done previously. Dr. Bailey and his associates
have been studying xenograft techniques on animal
models, chiefly sheep and goats - with varying
degrees of success and with the accumulation of a
large body of experimental data. The team's work

"As much experimental preparation had
been made as possible using animal
models."
included extensive tissue typing studies in baboons
and included the profusion of a baboon heart with
human blood - incidentally without apparent evidence
of rejection.
·What remained was the xenograft to a human host. In
looking for a human model, the hypoplastic left heart
syndrome was chosen because it was within Dr.
Bailey's competence as a pediatric thorasic surgeon
and because the condition untreated was uniformly
lethal. Success would, of course, have much broader
implications. Satisfaction of the criteria noted at the
beginning seemed assured. The animal studies
indicated that the procedure was well-tolerated. As
confirmation, Baby Fae's condition post-op was
obviously not an intolerable one. We have noted its
practicality above.
One of the startling results of this research was the
finding of a much greater histo-comparability (the key
figures seem to prefer this term to histo-compatabirity)
between humans and at least some baboons than had
previously been expected. Moreover, never had an
attempt been made on so young a patient with the
possible benefit of an immature immunological system
and its diminished tendency to reject.
Another difference was cyclosporine-A, a newer
immunosuppressive drug that has made a great deal of
difference to transplant technology. These three factors
constituted a basis for hope that this alternative might
offer a reasonable possibility of success - even a
greater possibility than any of the other options
including the human allograft - in the rare instance
that one were really available. (A human source is
obviously no guarantee against rejection. Allografts
are also rejected.) The other alternative was certain
death and Baby Fae came close to selecting it more
.
than once prior to surgery.
What we have had then, in the Baby Fae case, was a
slightly premature child facing certain death unless

(

something drastic were done to correct her congenital
heart defect. There were four options, all but the first
highly experimental and none of them good. (1) Death,
(2) the Norwood procedure, (3) a human allograft, and
(4) a baboon xenograft. The ethical requirement that
the incompetent patient's well-being take priority over

"5 he apparently died the death of an
allograft rejection rather than that of a
xenograft."
purely experimental purposes demanded that the best
available option be selected even if this interfered
temporarily with experimental goals.
Option (1) death, was unacceptable by all of the
tenents of medicine, providing a reasonable quality of
life was a possibility. (2) The Norwood procedure had
serious problems including an unacceptably high
mortality rate and a reduced quality of life. (3) A human
allograft was impractical as a solution to the larger
organ transplant problem and presented specific
insurmountable difficulties for the newborn which
leaves us with (4), the baboon xenograft. In this case,
because of newer information and better immunosuppressant drugs, while there remain large questions,
there was provided a real measure of hope. If it were
successful, it would not only offer a practical solution

to the Baby Faes among us but a host of other
possibilities down the line. On balance, (4), as
questionable as it was, offered at least as great, and
possibly greater therapeutic hope than either (2) or (3).
We would not know if the xenograft were not attempted.
As much experimental preparation had been made
as possible using animal models. Proper consent was
apparently provided including the protection of the
incompetent. Therapeutic goals were sought rather
than purely experimental ones; that is, that the baby
was considered to be more important than the
experiment.
Baby Fae lived almost 3 weeks after surgery,
apparently at least two good weeks. This was much
longer than any other xenograft had ever survived. And
when she died she apparently died the death of an
allograft rejection rather than that of a xenograft. An
enormous amount of information has been accumulated that may augur well for the future. Was it worth it?
Only the future will tell us for sure. But at least it seems
that those involved have acted with ethical responsibility in the past and the present.
Jack W. Provonsha, a minister, physician, and teacher with degrees from
Pacific Union College, Lorna Linda University, Harvard University, and
Claremont Graduate School, is the first Director of the Center for Christian
Bioethics. He serves as Professor of Philosophy of Religion and Christian
Ethics at Lorna Linda as well. Professor Provonsha and his wife Margaret,
also a physician, divide their time between their home in Yucaipa ,
California and their "hideaway" near the Puget Sound.

THE MORALITY OF EXPERIMENTING
UPON CHILDREN
David R. Larson
At least three views prevail today regarding the
morality of performing medical experiments upon
children. Each view possesses a distinCtive intellectual
history. Each view includes its own assumptions and
implications. And each view provides a vantage point
from which to survey the deci~ion to transplant a

"Research can be morally right, utilitarians
argue, if the good it produces for the
community outweighs the evil it entails."
baboon's heart into Baby Fae.
The utilitarian view is probably the most permissive.
It holds that a medical experiment can be justified
ethically if it promises to benefit society in the long run.
Utilitarians, the modern followers of Jeremy Bentham
(1748-1832) and John Stuart ~ Mili (1806-1873), are
directly concerned about the "common good." They
are indirectly concerned about protecting individuals
to the degree that such efforts benefit society. Even if
the one upon whom an experiment is performed is a
child, and even if the study is not designed to benefit
that particular youngster, the research can be morally
right, utilitarians argue, if the good it produces for the
community outweighs the evil it entails.
Utilitarians will disagree with each other regarding
the social value of Baby Fae's surgery. Some will
applaud it as an attempt to develop a steady source of

inexpensive and healthy organs. Others will criticize it
for spending so much to solve a rare malady when
there are cheaper ways to improve the public's health.
And utilitarians will advance other arguments both pro
and con. But all utilitarians will be primarily concerned
about the impact of such experiments upon the total
well-being of society.
The Kantian view is probably the most restrictive.
Princeton University's Paul Ramsey, a contemporary
thinker who is informed by I mmanuel Kant's (17241804) insistence that a person should never be treated
as a mere means to something else, holds that it is
morally right to perform a medical experiment upon a
child if and only if the researchers intend to help that
particular boy or girl. Ramsey believes that a child
cannot give competent, free, and informed consent for
an experiment that is designed to benefit others, and
that no one else, not even the child's parent or legal

"Kantian moralists will be primarily concerned about protecting children against
experimentation from which they cannot
benefit."
guardian, is morally authorized to approve such
"treatment." He refers to the practice of performing
nontherapeutic experiments upon children, with or
without parental consent, as a "sanitized form of
barbarism."
(continued on page 6)
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continued

Kantian thinkers will debate the therapeutic nature of
Baby Fae's surgery. No responsible person will doubt
that Doctor Bailey and his team intended to help their
dying patient by replacing her heart with that of a
baboon. But some will wonder if in November of 1984
there was enough favorable evidence to make this
attempt at cross-species transplantation a prudent
gamble. Others will wonder how promising the odds
must be before an experiment can be called "therapeutic" when it is certain that the patient will die and
when the only other medical options are virtually
palliative. Still others will doubt that ethicists have the
right to tell others what odds they may accept for their
children, or that they have the professional competence
to pass judgment upon the scientific feasibility of a
therapeutic venture. I n any case, Kantian moralists will
be primarily concerned about protecting children
against experimentation from which they cannot
benefit.
.
It is not as though only utilitarians are interested in
social benefits and only Kantians are concerned about
protecting individuals. But the relative importance

"McCormick balances the protection of
individuals and the betterment of society
upon the validity of parental consent."
placed upon either consideration does vary from group
to group, as do the intellectual justifications for the
conclusions that each group defends.
The view of some thinkers who represent the natural
law tradition initiated by Thomas Aquinas (1225-1274)
and others is less permissive than the utilitarian view
but also less restrictive than the Kantian view. Richard
McCormick, for instance, believes that the consent of a
parent or legal guardian may properly authorize a nontherapeutic experiment upon a child providing certain
provisions are met. These requirements stipulate that
the parents choose with competence, knowledge, and
freedom; that the experiment is designed so as to yield
significant results; that the project cannot succeed
without the use of children; and that the venture
imposes no undue risk or discomfort upon the

"I am more impressed by the arguments in
favor of the surgery than I am by those
against it, whether permissive, restrictive,
or moderate."
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youngster. McCormick balances the protection of
individuals and the betterment of society upon the
validity of parental consent in carefully delineated
circumstances.
Those who take a moderate position something like
McCormick's will be particularly interested in the
process by which Baby Fae's parents gave their
consent. Some will wish that the form they signed was
longer and more technical. Others will argue for a brief
and to-the-point document. Some will contend for a
"patient's advocate." Others will insist that Baby Fae's
parents were the best advocates she could have had.
Some will contend that the details of the process and
the consent form itself should be made public. Others
will respect the desire to keep such things confidential.

But the validity of parental consent will dominate the
thinking of those who cannot condemn or condone the
transplantation for either its social benefits or its
therapeutic intentions alone.
I am more impressed by the arguments in favor of the
transplantation than I am by those against it, whether
permissive, restrictive, or moderate. I think the
surgery's social benefits outweighed its costs. I am
persuaded that there was a clear intention to benefit
Baby Fae and that her parents had a right to give her a
chance despite the odds. And I am of the view that the
consent process was adequate even though it can be
refined. But more than anything else, I respect the
courage, creativity, and compassion with which Doctor
Bailey and his team struggled to save the life of one
little girl.
David R Larson is Associate Professor of Christian Ethics and Religion
and Associate Director of the Center for Christian Bioethics at Loma Linda
University. A graduate of Pacific Union College, the School of Theology at
Claremont, and Claremont Graduate School, he lives near Lake Elsinore
with his wife Judy, a commercial artist, their two sons and daughter.

ISSUES EVOKED (continued from page 3)
heart, LLU Medical Center expended less than two
million dollars developing its cross-species heart
transplant procedure.
If Baby Fae-type operations become successful,
their allocation and cost will be another question. Heart
transplants for some babies pose profound questions
when many babies in our nation receive inadequate
prenatal care and sti II others starve to death in droughtstricken areas of the world.
4. Do baboons have a right to life? Yes. A moral
argument can be made that all sentient animals, on an
ascending scale, have a prima facie right to life. But is
that the essential issue here? If the cross-species heart
transplant has a reasonable chance for success, we
cease to deal in animal/human abstractions and we
begin weighing the life of a human newborn vs. the life
of a young baboon. Most persons rightly favor the
human infant. For those who do object to the sacrifice
of baboons, there is a much more pressing issue: our
society's mass, and often cruel, slaughter of millions of
animals for our dinner tables.
No facile answer will suffice. Do we really want large
farms of high-level primates which we harvest for
hearts and livers? If it were found that an endangered
species of primates had the greatest immunological
compatability with humans, what should we decide?
The more general question for all medical research
is not whether there should be medical progress even at the risk of possible human suffering. The issue
is how that progress is made. Great ethical sensitivity is
our only safeguard in preventing some future wellmeaning researcher from performing the ill-considered.
Finally, I see two overriding issues in innovative
human treatment: motivation and procedure. In this
case, the dedicated perserverance of Doctor Bailey's
team to the saving of Baby Fae's beautiful little life is a
model of self-giving for medical science and an
exemplar of humanness for us all.
James W. Walters is Assistant Professor of Christian Ethics and Religion
at Lama Linda University. He is also the chairman of the Ethics Center's
Finance Committee. Professor Walters, who graduated from Southern
College, Andrews University, and Clammont Graduate School served as a
pastor in the southeastern and southwestern portions of this country
before moving to Claremont where he now resides with his wife Priscilla, a
physical therapist, and their two daughters.

WHO SHOULD LIVE
WHEN NOT ALL CAN?
Triage and Justice by Gerald R. Winslow. Berkeley:
University of California Press, 221 pp., bibliography,
index. Reviewed by Brent T. Stanyer, graduate student,
Lorna Linda University.
The question "Who should live when not all can?"
has been asked throughout medical history. The
answers to that question have been as varied as the
individuals involved. The process of al/ocating resources in times of scarcity, called triage, is the subject
of Triage and Justice by Gerald R. Winslow.
Winslow begins by tracing the history of triage from
its first use in the late eighteenth century to the present.
Triage was first used in military medicine during the
Napoleonic wars by Baron Dominique Larrey. During
World War I it became an integral part of military
medicine as the number of casualties exceeded the
availability of treatment. The development of new
medicines during World War " and new medical
technologies in the postwar era led to the use of triage
in civilian medicine, especially with hemodialysis for
the treatment of end-stage renal disease.
After examining these historical developments,
Winslow develops two "prismatic cases" through
which the principles of triage may be seen. First,
planning for a San Francisco earthquake, and second,
) allocation of the totally implantable artificial heart
(TIAH). By examining medical decision-making during
a hypothetical earthquake, the principles of triage may
be applied to emergency medicine in a natural disaster.
In the case of the artificial heart, the focus is on the
allocation of a scarce new technology.
Before presenting his own principle for triage,
Winslow examines the utilitarian and egalitarian
approaches to decision-making . Utilitarian approaches
are concerned with the total amount of some good
such as happiness or social worth. Egalitarian
approaches, on the other hand, are concerned with
equal access regardless of other factors. These two
approa<.;hes have provided the basis for most of the

triage decisions in the past.
At this point Winslow outlines these approaches in
light of the theory of justice of John Rawls. Rawls' basic
position is that justice as fairness entitles all to an equal
distribution of basic liberties. Inequities are also
distributed equally, though Rawls does allow that
inequities may be adjusted to reach the "greatest
benefit for the least advantaged." (p. 116) Rawls'
approach is basically an egalitarian one in which all
would compete on an equal basis for any scarcities
unless the scarcities were so dire as to rule out any
possibility of a just distribution .
Winslow adopts Rawls' theory of justice and applies
it to the decision-making involved in triage. The
"bottom-line" is fairness and impartiality for all. Resources are allocated on a fair and equal basis through
some method of random distribution to ensure that
impartiality. However, the basic nature of providing
medical care and the need for medical personnel and
resources during emergency situations may warrant
consideration of some utilitarian principles. For
instance, the prinCiple of medical neediness is basic to
the allocation of care. Therefore candidates for treatment would have to pass the test of medical need. Also,
the principle of immediate usefulness in a medical
emergency might warrant the giving of priority to
medical personnel so that they might provide care to
others, But before these utilitarian principles may be
considered it must be proven that they bear the burden
of proof.
Winslow clearly defines the issues involved with
triage and applies the principles in a clear and
consistent manner. He examines the assets and
liabilities of both utilitarian and egalitarian principles,
and although Winslow sides with the egalitarian
principleof justice as fairness , he is no pure egalitarian .
Various utilitarian principles supplement his approach .
I would have liked, however, to have seen more
attention given to approaches other than util itarianism
and egalitarianism . The libertarian argument, for
example, is very much a part of our free market
economy and is held by a number of people. Though I
do not agree with that argument, Winslow's treatise
would have been more complete if approaches such as
this one had also been considered.
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John D. Ruffcorn, President of
the Loma Linda University Medical
Center, announced last summer
that his institution will contribute
$10,000.00 per year toward the
operating expenses of the Center
for Christian Bioethics "for the
indefinite future." This commitment, which approximates the
annual yield from a $100,000.00
endowment, was Mr. Ruffcorn'S
response to requests made in behalf
of the Ethics Center by Bruce
Branson, Chairman of Loma Linda
University's Department of Surgery,

and V. Norskov Olsen, the University's former president.
"This contribution is a gift that is
making many other gifts possible,"
explained David Larson, the Ethics
Center's Associate Director. "We
are using the money from the Medical Center to contact individuals
and groups who can contribute to
the endowment. Without President
Ruffcorn's support, our attempts to
develop the endowment would have
been stopped before they even
started for lack of the money it takes
to raise money."
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The Ethics Center will shortly
receive $50,000 from Dr. and Mrs.
Ronald Cafferky toward a $100,000
special endowment. "This demonstration of confidence is most
heartening," said Jack Provonsha,
Center director. "It is this type of
gift which assures the future of our
fledgling ethics institute."
The Ladd Endowment Fund, as
the gift will be called, is made to
Loma Linda University in honor of
the parents of Anita Ladd Cafferky.
Ervin E. Ladd graduated from LLU
School of Medicine in 1948 and
passed away in 1977. Margaret J .
Ladd is now living in Lincoln City,
Oregon. The gift is made in the
name of the four Ladd children: E.
David Ladd, R. Hudson Ladd, Anita
Ladd Cafferky, and Nyra Thompson,
married to Albert Thompson, M.D.
"Our family deeply appreciated
Dr. Provonsha's insight at a crucial
time when my father was dealing
with his terminal illness," Anita
Cafferky explained. "Ideally, these
life-and-death issues should be
thought out in advance of the emergency. However, so often that is not
the case. It is important that someone of the caliber of Dr. Provonsha
be available to give guidance. Our
gift is intended to encourage ethical
research and provide a helpful resource for others when it is needed."
The Cafferky family, which includes four young children, resides
in Claremont, California, where Ron
Cafferky, also an alumnus of the
LLU School of Medicine, practices
psychiatry.
The Ladd Endowment Fund will
supplement the Center's basic
endowment. "A robust endowment
fu nd is vital so that the Center can
rise above a precarious hand-tomouth existence and devote its
energies to ethics," says James
Walters, development committee
chairperson. "We're all deeply
grateful to the Cafferkys for their
generosity."
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CENTRAL AMERICA PROBE
(continued from page 1)

for the College of Arts and Sciences
entitled "Liberationists and Evangelists: Logging a Passage through
Mexico and Central America." Teel's
other research interests include the
life and thought of Martin Luther
King, Jr., the social views of the
Millerites in 19th century America,
and the history of Seventh-day
Adventist ethical thought. Doctor
Teel, a graduate of Pacific Union
College, Andrews University, Harvard Divinity School, and Boston
University is an ordained Seventh day Adventist minister actively
engaged in preparing materials for
congregational worship. He teaches
courses for pastors who lead worship as well.
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ETHICS CENTER SEEKS $500,000
A $500,000 endowment is the
goal of the Ethics Center's campaign
to secure its existence and provide
financial stability. Gifts and commitments total over $160,000 to
date. "This is a significant beginning," commented James Walters,
chairperson of the development
committee, "but we hope many will
catch the vision of our potential and
help assure the Ethics Center's
future." One administrator of a large
medical center suggested that the
financial goal's decimal point was
in the wrong place, that $5 million
would be a more adequate goal,
said Walters.
A threefold effort in fund raising
is underway, beginning with a letter
campaign. Dr. Jack Provonsha, Director of the Center and distinguished professor at Loma Linda
University, has personally sent letters to many of his former students.
He also has sent letters to subscribers of his Sabbath School
tapes, with recordings of a meeting
in which the Ethics Center was
discussed.
Secondly, meetings for persons
interested in the Center have been
held across the country. These
persons were invited to a dinner
which featured a lecture by Provon-

sha. Following the lecture, the financial needs of the Center were presented by one of Provonsha's colleagues: Charles Teel, Jr., David
Larson, or James Walters. After the
"nuts and bolts" of the Center were
presented, individuals were invited
to support the project. To dat'
meetings have been held in Glen
dale, Loma Linda; Palo Alto, San
Diego, St. Helena, and Tustin, California; Orlando, Florida; Hinsdale,
Illinois; Kettering, Ohio; and Portland, Oregon.
The third thrust of the campaign
is to seek su pport from corporate
entities and foundations . To date,
corporate support has come from
the Loma Linda University Medical
Center in the form of a $10,000 per
year commitment. Corporate support is also forthcoming from the
Wuchenich Foundation. The California Council forthe Humanities is
considering a proposal for a $10,000
grant to aid in the expenses of the
upcoming "Biomedical Ethics Today" conference.
The Center welcomes inquiries
regarding future plans and longterm needs. Write to Dr. Jack Provonsha, Director, The Ethics Center,
LLU, Loma Linda, CA 92350.
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